COVID-19General interestAcademic/ScientificNeurology updatesTop Articles Neurology Update: Epilepsy & COVID-19 June 6, 2020 Seizures as a Feature of COVID-19 Seizures appear to be a rare feature of COVID-19. Avoiding unintentional antiseizure medicine withdrawal during the COVID-19 pandemic is a potential challenge for people with epilepsy. Please read the full update here. Neurology Update: Epilepsy & COVID-19 was last modified: June 10th, 2020 by EditorShare this...FacebookTwitterLinkedin 0 comment previous post EAN BrainChallenge 2020 next post Neurology Update: Epilepsy & COVID-19 You may also like Neurology Update: Neurogenetics April 25, 2019 A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the European Academy of Neurology February 3, 2021 The BrainChallenge – second edition to take place in Oslo! May 1, 2019 Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial February 25, 2021 Country of the month: Austria June 1, 2020 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. May 6, 2020 Executive Page: Elena Moro elected as Secretary General July 3, 2020 Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection March 3, 2021 Impact of COVID-19 on management of epilepsy April 3, 2020 Abstract Submission is open December 15, 2020 Leave a Comment Cancel ReplyYou need to be logged in to comment. Please login to MyEAN on top.